Article metrics

Download PDFPDF

586 Phase II study of Telomelysin (OBP-301) in combination with pembrolizumab in gastroesophageal (GEA) adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023404020
Dec 2023145014
Jan 20245208
Feb 20244204
Mar 20247005
Apr 20247206
May 20244203
Jun 20245003
Jul 20244605
Aug 20245008
Sep 20244201
Oct 20245805
Nov 20243409
Dec 20243606
Jan 20255003
Feb 20252408
Mar 2025008
Apr 2025004
May 2025007
Jun 2025206
Total12190133